PROCTER & GAMBLE Co 4

Procter & Gamble Health Care CEO Paul Gama received routine retirement-related RSU/dividend-equivalent grants and minor plan adjustments totaling about 279 new common-share-equivalent units, with no open-market buys or sells.

On this Form 4, Procter & Gamble Health Care CEO Paul Gama reported routine equity-related transactions consisting of dividend-equivalent restricted stock units (RSUs) credited under the company’s retirement program and plan-related conversions, with no open-market purchases or sales. On May 15, 2026, he received 7.0873 RSUs (event code 5) that were credited and immediately reflected as 7.0873 shares of common stock held directly, and on July 14, 2026 a small 0.1051-share adjustment was made from Series A Preferred Stock into common stock held indirectly in the retirement plan. On August 6, 2026, he received an additional 272 RSUs (event code 4) as a retirement award or dividend-equivalent grant, which are to be settled in common stock (or, for some awards, potentially in cash) at or after retirement; this 272-unit grant is valued at approximately $39,600 based on the current share price. After these transactions, Gama beneficially owns approximately 36,226 shares of P&G common stock directly plus around 1,173.5 shares indirectly through the retirement plan, for a total stake of roughly 37,399 shares, representing an estimated $5.45 million in current value using the indicated market price context.

Filing Facts

CIK

80424

Ticker

PG

Form

4

Source Type

sec

Accession

0000080424-26-000113

Alert Tier

5